These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16865956)

  • 21. Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1).
    Kesik M; Jedlina-Panasiuk L; Kozak-Cieszczyk M; Płucienniczak A; Wedrychowicz H
    Vaccine; 2007 May; 25(18):3619-28. PubMed ID: 17289224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarray analysis of rat immune responses to liver fluke infection following vaccination with Fasciola hepatica phosphoglycerate kinase.
    Wesołowska A; Jaros S; Norbury LJ; Jaros D; Zygner W; Wędrychowicz H
    Exp Parasitol; 2013 May; 134(1):33-8. PubMed ID: 23376446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection.
    Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Januszkiewicz K; Pyziel AM; Zygner W; Wędrychowicz H
    Acta Parasitol; 2016 Mar; 61(2):212-20. PubMed ID: 27078643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasciola hepatica in rats: transfer of immunity by serum and cells from infected to F. hepatica naive animals.
    Rajasekariah GR; Howell MJ
    J Parasitol; 1979 Aug; 65(4):481-7. PubMed ID: 512746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of free radicals by peritoneal cells of sheep during the early stages of Fasciola hepatica infection.
    Pérez-Caballero R; Buffoni L; Martínez-Moreno FJ; Zafra R; Molina-Hernández V; Pérez J; Martínez-Moreno Á
    Parasit Vectors; 2018 Sep; 11(1):500. PubMed ID: 30189903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersensitivity in rats infected with Fasciola hepatica: possible role in protection against a challenge infection.
    Doy TG; Hughes DL; Harness E
    Res Vet Sci; 1981 May; 30(3):360-3. PubMed ID: 7255931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serum glucose and beta-hydroxybutyrate levels in sheep with experimental Fasciola hepatica and Fasciola gigantica infection.
    Phiri IK; Phiri AM; Harrison LJ
    Vet Parasitol; 2007 Feb; 143(3-4):287-93. PubMed ID: 17011709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The immune response of various species to Fasciola hepatica infection].
    Jedlina-Panasiuk L
    Wiad Parazytol; 2002; 48(1):11-21. PubMed ID: 16883699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of accessory activity of peritoneal cells from Fasciola hepatica infected rats.
    Masih DT; Cervi L; Casado JM
    Vet Immunol Immunopathol; 1996 Oct; 53(3-4):257-68. PubMed ID: 8969046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic responses of parasite-specific antibody isotypes, blood leucocyte pattern and lymphocyte subsets in rats during primary infestation with Fasciola hepatica.
    Poitou I; Baeza E; Boulard C
    Vet Parasitol; 1993 Sep; 49(2-4):179-90. PubMed ID: 8249242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism.
    Serradell MC; Guasconi L; Cervi L; Chiapello LS; Masih DT
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):197-208. PubMed ID: 17449115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the hepatic NK cell response during the early phase of Fasciola hepatica infection in rats.
    Tliba O; Chauvin A; Le Vern Y; Boulard C; Sbille P
    Vet Res; 2002; 33(3):327-32. PubMed ID: 12056483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfer of immunity to Fasciola hepatica infection by lymphoid cells.
    Corba J; Armour J; Roberts RJ; Urquhart GM
    Res Vet Sci; 1971 May; 12(3):292-5. PubMed ID: 5581695
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful DNA immunisation of rats against fasciolosis.
    Kofta W; Mieszczanek J; Płucienniczak G; Wedrychowicz H
    Vaccine; 2000 Jul; 18(26):2985-90. PubMed ID: 10825600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the liver of goats immunized with a synthetic peptide of the Sm14 antigen and challenged with Fasciola hepatica.
    Zafra R; Buffoni L; Martínez-Moreno A; Pérez-Ecija A; Martinez-Moreno FJ; Pérez J
    J Comp Pathol; 2008 Nov; 139(4):169-76. PubMed ID: 18768187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum transfer of immunity to Fasciola hepatica in rats.
    Hayes TJ; Bailer J; Mitrovic M
    J Parasitol; 1974 Aug; 60(4):722-3. PubMed ID: 4854263
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of vaccination of calves with recombinant cysteine proteinase of Fasciola hepatica on development and infectivity of miracidia].
    Dabrowska M; Kaliniak M; Wedrychowicz H
    Wiad Parazytol; 2006; 52(4):305-9. PubMed ID: 17432623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Killing of juvenile Fasciola hepatica by purified bovine eosinophil proteins.
    Duffus WP; Thorne K; Oliver R
    Clin Exp Immunol; 1980 May; 40(2):336-44. PubMed ID: 7438542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.